RESUMEN
AIM OF THE STUDY: The first aim was to investigate the knowledge and awareness of oncologists concerning febrile neutropenia (FN) risk assessment and indications for granulocyte colony-stimulating factor (G-CSF) primary prophylaxis (PP), based on current therapeutic guidelines (PTOK and EORTC). The second aim was to educate the oncologists on best practices for risk assessment and neutropenia management. MATERIAL AND METHODS: The project participants included 169 oncologists from 7 regions working in large specialist oncological centres, university hospitals, regional and city hospitals, specialist outpatient clinics, and oncological wards in small local hospitals. The participants completed a questionnaire based on seven prepared clinical cases of patients with different tumour types and patient characteristics, receiving chemotherapy (CT), and with different levels of FN risk. Participants answered questions related to FN risk assessment and G-CSF use. After completing the questionnaire, the participants proceeded to an educational module in which they were provided with an analysis of correct diagnostic and therapeutic procedures according to the PTOK and EORTC guidelines. RESULTS AND CONCLUSIONS: Febrile neutropenia risk assessment was found to be a routine procedure performed for over 90% of the clinical cases by the participant oncologists. However, the FN risk assessment of clinical cases was correct and consistent with therapeutic guidelines in only 65% of responses. Indications for G-CSF PP were properly identified in 76% of responses and it appeared that indications for G-CSF PP were more likely to be correctly identified in patients receiving high-risk or low-risk regimens than in those receiving intermediate-risk regimens, where the decision to give G-CSF PP is based on additional assessment of patient risk factors. The vast majority of participants who correctly identified the need for PP administered G-CSF in accordance with the dose and schedule recommended by PTOK and EORTC.
RESUMEN
AIM OF THE STUDY: This paper presents the second part of the GoPractice project involving oncologists from seven Polish provinces. The aim of this part of the project was to assess the knowledge of oncologists on indications for granulocyte colony-stimulating factor (G-CSF) secondary prophylaxis (SP) of febrile neutropenia (FN) and FN management based on current therapeutic guidelines (Polish Society of Clinical Oncology [PTOK] and European Organisation for Research and Treatment of Cancer [EORTC]). MATERIAL AND METHODS: The project involved 169 oncologists from 7 regions working in large specialist oncological centers, university hospitals, regional and city hospitals, specialist outpatient clinics and oncological wards in small, local hospitals. The participants completed a questionnaire based on 7 prepared clinical cases of patients with different tumor types and patient characteristics, receiving chemotherapy (CT) with different levels of FN risk. Participants answered questions related to FN risk assessment and G-CSF use as secondary prophylaxis (SP) and for the management of FN. After completing the questionnaire, the participants proceeded to an educational module in which they were provided with an analysis of correct diagnostic and therapeutic procedures according to the PTOK and EORTC guidelines. RESULTS AND CONCLUSIONS: Indications for G-CSF SP were generally well recognized: in nearly 90% of responses, oncologists assessed correctly indications/lack of indications for secondary prophylaxis, in accordance with guideline recommendations and Experts' opinion. However, the use of daily G-CSFs was often recommended by the study participants for the management of FN. This clinical practice is contradictory to PTOK and EORTC recommendations and may unnecessarily increase treatment costs. Changing this clinical approach may be achieved through regular training to improve guideline adherence.
RESUMEN
Schizophrenia is a social disease that occurs in 0.5-1% of the population. It shows a high variability in both clinical picture and theory of its pathogenesis. Its clinical manifestations are accompanied by biochemical, immunological and structural changes. A pivotal role in the development of psychotic disorders is attributed to the impaired limbic system. The aim of this study was to find out whether, and if so, to what extent immunocompetent cells of the central nervous system (microglia) are involved in the process of degeneration occuring in these structures. The study was carried out on 12 brains of female chronic schizophrenics. Sections of frontal and temporal cortex were subjected to ultrastructural as well as histochemical and immunohistochemical examinations by light microscopy. In the structures under study, a large number of ramified microglial cells showing on their surface the expression of the major histocompatibility complex class II (MHC II) was observed. Most cells showed degenerative traits (cytoplasm shrinkage, thinning, shortening and fragmentation of their processes) up to apoptotic changes. Perivascular microglia displayed the lowest intensity of degenerative changes. Ultrastructurally, some damaged microglial cells contained phagosomes and/or degenerated mitochondria. Most abnormal microglia showed morphological signs of the former normal function of immunocompetent and phagocytosing cells. Degeneration of microgial cells, resulting most likely from the primary impairment of the neuron-glia communication that damages their immunocompetent function, may lead to the exacerbation of structural damage and psychotic symptoms. Treatment of chronic schizophrenics should involve the supply of agents to prevent degeneration of microglia and/or long-term immunotherapy.
Asunto(s)
Lóbulo Frontal/patología , Microglía/metabolismo , Esquizofrenia/patología , Lóbulo Temporal/patología , Adulto , Anciano , Apoptosis/fisiología , Femenino , Lóbulo Frontal/ultraestructura , Antígenos de Histocompatibilidad Clase II/metabolismo , Humanos , Inmunohistoquímica , Microglía/ultraestructura , Microscopía Electrónica , Persona de Mediana Edad , Lóbulo Temporal/ultraestructuraRESUMEN
Activated forms of microglia were ultrastructurally evaluated in three neurological diseases of different aetiology (subacute sclerosing panencephalitis--SSPE, Wilson's disease and Alzheimer's disease). The occurrence of activated rod, ramified and amoeboid microglia was found in the investigated diseases. The widest ultrastructural variability of microglia was in SSPE, including the presence of mitotic chromosomes or centrioles in its cytoplasm, which indicates microglia proliferation. In the nuclei of activated microglia, some nuclear bodies with different structures were frequently seen, whereas lamellar structures (similar to developing Birbeck's bodies--pathognomonic to Langerhans-type dendritic cells) were observed in the cytoplasm. The activated forms of microglia with apoptotic features were found only in SSPE cases. Some apoptotic nuclei were filled with nucleocapsids of measles virus. In Alzheimer's disease, activated microglia was most frequently bound to senile plaques. Ramified microglia was in contact with amyloid fibrils, which penetrated its cytoplasm and reached the nuclear membrane and channels of rough endoplasmic reticulum, or was situated among dystrophic neurites. Rod microglia was found predominantly at the edge of senile plaques. In Wilson's disease, the ultrastructure of activated microglia showed mostly indirect forms between rod, ramified and amoeboid microglia. The microglia ultrastructure suggests that its morphological form may express functional involvement in the pathogenesis of a given disease entity.
Asunto(s)
Enfermedad de Alzheimer/patología , Encéfalo/ultraestructura , Degeneración Hepatolenticular/patología , Microglía/metabolismo , Microglía/ultraestructura , Panencefalitis Esclerosante Subaguda/patología , Adolescente , Adulto , Enfermedad de Alzheimer/metabolismo , Encéfalo/patología , Niño , Femenino , Degeneración Hepatolenticular/metabolismo , Humanos , Masculino , Microglía/patologíaRESUMEN
Alcohol ingestion by female rats during pregnancy and/or lactation leads to developmental anomalies of different organ systems, retardation and immune system impairment in their offspring. In humans, these disorders are termed foetal alcohol syndrome (FAS), or foetal alcohol effect (FAE) if abnormalities are of lesser degree. The study materials consisted of brain, liver and spleen samples collected ten days post partum from neonatal rats born to dams treated with 12% alcohol at a dose of 6 g/kg body mass during pregnancy or during pregnancy and/or lactation. Microglial and dendritic cells were assessed by light (histochemical and immunohistochemical methods) and electron microscopes. Histochemically, the presence of microglia (ramified, amoeboid and rod) and dendritic cells in the studied organs was detected, but only some of them demonstrated the expression of major histocompatibility complex, class I and II (MHC I, II) on their surfaces. Ultrastructural observations revealed immature morphology of part microglial cells, whereas their euchromatin nuclei maybe showed rather high transcription activity. The preliminary study of dendritic cells at ultrastructural level does not indicate pronounced changes. Abnormalities were mostly pronounced in pups born to alcohol-treated dams during pregnancy and during pregnancy and lactation. These observations suggest that microglia and dendritic cells may be regarded as early markers of alcohol-induced impairments. The reduced immune efficiency in animal FAS/FAE models may be due to both immaturity of these cells and low expression of MHC I and II molecules, which renders it difficult for microglial and dendritic cells to present foreign antigens to helper lymphocytes T, which delays the cascade of immune response.
Asunto(s)
Dendritas/efectos de los fármacos , Etanol/farmacología , Microglía/efectos de los fármacos , Efectos Tardíos de la Exposición Prenatal , Animales , Animales Recién Nacidos , Dendritas/patología , Etanol/sangre , Femenino , Lactancia/sangre , Lactancia/efectos de los fármacos , Microglía/patología , Embarazo , Ratas , Ratas WistarRESUMEN
Acardiac twinning is a very rare complication of multiple pregnancy. The authors present the neuropathological and anatomopathological description of the twins of the multiple pregnancy complicated by the acardiac foetus and terminated at 26 weeks of gestation. An anatomopathological examination of the "normal" twin showed hyaline membrane syndrome, cardiomegaly and hepatomegaly. Neuropathologically, numerous hypoxic-ischaemic lesions, most likely associated with haemodynamic disorders during pregnancy as well as less pronounced perinatal changes were revealed. The acardiac foetus, classified as acardius acephalus, demonstrated the presence of some abdominal organs and a histologically well-developed spinal cord. In view of the neuropathological changes, monitoring "normal" twins for discreet pathological central nervous system signs, which may be similar in character to those described, may play a significant role.
Asunto(s)
Anomalías Teratoides Graves/patología , Encéfalo/patología , Enfermedades en Gemelos/diagnóstico , Enfermedades Fetales/patología , Cardiopatías Congénitas/patología , Adulto , Encéfalo/anomalías , Femenino , Cardiopatías Congénitas/diagnóstico , Humanos , Embarazo , Hermanos , GemelosRESUMEN
The morphological background of cognitive and emotional impairments in Parkinson's disease (PD) has not yet been fully explained. We evaluated the expression of synaptic proteins: alpha- and beta-synuclein, synaptophysin and synaptobrevin and ultrastructural changes of perikaryons and axons in limbic structures at post-mortem from cases of PD to estimate degenerative axonal pathology in the hippocampus and amygdala [corrected]. Limbic structures (enthorinal cortex, hippocampus, and amygdala) are essential for the cognitive processes and emotional behaviour. We found that presynaptic axon pathology is mostly connected with hippocampal CA2-3 and dentate hilar regions as well as with the cortical and medio-central complexes of amygdala. Heterogeneous immunoreactivity of alpha-synuclein and diversified ultrastructure of Lewy bodies (LBs) and Lewy neurites (LNs) indicate their consecutive developmental stages. We observed an excessive perineuroneal expression of synaptophysin in the dentate hilar region in all PD cases, except one. This suggests that the dysfunction of synapses in this region may result from axonal pathology. Our study indicates a relation between cognitive and behavioural symptomatology in PD and alpha-synuclein dependent axonal pathology in the hippocampus and amygdala.
Asunto(s)
Amígdala del Cerebelo/patología , Axones/patología , Hipocampo/patología , Degeneración Nerviosa/patología , Enfermedad de Parkinson/patología , Anciano , Anciano de 80 o más Años , Amígdala del Cerebelo/metabolismo , Amígdala del Cerebelo/ultraestructura , Axones/metabolismo , Axones/ultraestructura , Femenino , Hipocampo/metabolismo , Hipocampo/ultraestructura , Humanos , Inmunohistoquímica , Cuerpos de Lewy/patología , Cuerpos de Lewy/ultraestructura , Masculino , Proteínas de la Membrana/metabolismo , Microscopía Electrónica , Persona de Mediana Edad , Degeneración Nerviosa/metabolismo , Proteínas del Tejido Nervioso/metabolismo , Ovillos Neurofibrilares/patología , Ovillos Neurofibrilares/ultraestructura , Enfermedad de Parkinson/metabolismo , Placa Amiloide/patología , Placa Amiloide/ultraestructura , Proteínas R-SNARE , Sinaptofisina/metabolismo , Sinucleínas , alfa-Sinucleína , Sinucleína betaRESUMEN
The activation of microglial cells in pathological conditions is manifested primarily by their proliferation, as well as by the occurrence of a new morphological form--rod microglia. In the present study immunohistochemical identification of rod microglial phenotype against ramified microglia was performed on segments of 17 brains derived from 7 cases of encephalitis of viral aetiology (including 5 SSPE cases), 6 cases of Wilson's disease and 4 cases of Alzheimer's disease. Segments from frontal, temporal and occipital lobes, cerebellum and brainstem were subjected to histological, histochemical and immunohistochemical reactions. The presence of activated rod and ramified microglia was observed in sections derived from all structures of the brains under study. Both morphological forms of activated microglia reacted to antibodies: HLA II, CD68, HAM56 and lectin RCA-1. Expression of HLA II molecules was less intensive on the surface of microglial rod cells. A positive reaction to PCNA antibody was mainly observed in rod/elongated/cylinder-shaped nuclei, which is a characteristic feature of rod microglia. In the study material, the localisation of microglial processes seemed to depend rather on the structural topography of the cell in the brain than on the nuclear shape of the activated microglial cell. Our observations revealed a strong similarity between immunohistochemical phenotypes of both morphological forms of microglia with the indication that rod microglia is a first developmental form of activated microglia.